Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet- induced obesity and type 2 diabetic rats

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 3, 2014, Pages 1222-1230

  Davidson, Eric P ^a   Coppey, Lawrence J ^a   Kardon, Randy H ^a,b   Yorek, Mark A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Veterans Administration   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Cornea; Diabetes; Diabetic neuropathy

Indexed keywords

AQUAPORIN; AQUAPORIN 0; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; CORNEA OPACITY; EYE PHOTOGRAPHY; FREEZE FRACTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOGOLD LABELING; LENS; LENS FIBER; MICROSCOPY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

CORNEA; DIABETES; DIABETIC NEUROPATHY;

ANIMALS; CELL COUNT; CORNEA; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; MALE; MICROSCOPY, CONFOCAL; NERVE FIBERS; OBESITY; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SENSATION;

EID: 84897610965     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13794     Document Type: Article

References (33)

1. Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009; 9: 432-434.
2. Yorek MA. The potential role of angiotensin converting enzyme and vasopeptidase inhibitors in the treatment of diabetic neuropathy. Curr Drug Targets. 2008; 9: 77-84.
3. Davidson EP, Coppey LJ, Calcutt NA, Oltman CL, Yorek MA. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev. 2010; 26: 306-318.
4. Singleton JR, Smith AG. Neuropathy associated with prediabetes: what is new in 2007? Curr Diab Rep. 2007; 7: 420-424.
5. Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with impaired glucose tolerance: implications for diagnosis and therapy. Curr Treat Options Neurol. 2005; 7: 33-42.
6. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007; 56: 2148-2154.
7. Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy. A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care. 2010; 33: 1792-1797.
8. Tavakoli M, Kallinikos P, Iqbal A, et al. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet Med. 2011; 28: 1261-1267.
9. Malik RA, Kallinikos P, Abbott CA, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003; 46: 683-688.
10. Tavakoli M, Hossain P, Malik RA. Clinical applications of corneal confocal microscopy. Clin Ophthalmol. 2008; 2: 435-445.
11. Yin J, Huang J, Chen C, Gao N, Wang F, Yu FS. Corneal complications in streptozotocin-induced type 1 diabetic rats. Invest Ophthalmol Vis Sci. 2011; 52: 6589-6596.
12. Petropoulos IN, Alam U, Fadavi H, et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care. 2013; 36: 3646-3651.
13. Davidson EP, Coppey LJ, Holmes A, Yorek MA. Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat. Invest Ophthalmol Vis Sci. 2012; 53: 1182-1187.
14. Davidson EP, Coppey LJ, Holmes A, Dake B, Yorek MA. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. Eur J Pharmacol. 2011; 688: 497-506.
15. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Obesity. 2008; 16: 82-89.
16. Coppey LJ, Davidson EP, Dunlap J, Lund DD, Yorek MA. Slowing of motor nerve conduction velocity in streptozotocininduced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int J Exp Diabetes Res. 2000; 1: 131-143.
17. Obrosova IG, Li F, Abatan OI, et al. Role of poly (ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes. 2004; 53: 711-720.
18. Hossain P, Sachdev A, Malik RA. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet. 2005; 366: 1340-1343.
19. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007; 56: 2148-2154.
20. Pritchard N, Edwards K, Shahidi AM, et al. Corneal markers of diabetic neuropathy. Ocul Surf. 2011; 9: 17-28.
21. Pritchard N, Edwards K, Vagenas D, Russell AW, Malik RA, Efron N. Corneal sensitivity is related to established measures of diabetic peripheral neuropathy. Clin Exp Optom. 2012; 95: 355-361.
22. Davidson EP, Coppey LJ, Yorek MA. Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment. Invest Ophthalmol Vis Sci. 2012; 53: 8067-8074.
23. Nitoda E, Kallinikos P, Pallikaris A, et al. Correlation of diabetic retinopathy and corneal neuropathy using confocal microscopy. Curr Eye Res. 2012; 37: 898-906.
24. Wu T, Ahmed A, Bril V, et al. Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening. Diabet Med. 2012; 29: 297-303.
25. Ahmed A, Bril V, Orszag A, et al. Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diabetes Care. 2012; 35: 821-828.
26. Messmer EM, Schmic-Tannwald C, Zapp D, Kampik A. In vivo confocal microscopy of corneal small fiber damage in diabetic mellitus. Graefes Arch Clin Exp Ophthalmol. 2010; 248: 1307-1312.
27. Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst. In press.
28. Pop-Busui R, Herman WH, Feldman EL, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep. 2012; 10: 276-282.
29. Morimoto J, Suzuki Y, Tada A, Akui M, Ozawa Y, Maruyama T. Time-course changes in nerve conduction velocity (NCV) in type 2 diabetes. J Diabetes Complications. 2012; 26: 237-240.
30. Dvorscak L, Marfurt CF. Age-related changes in rat corneal epithelial nerve density. Invest Ophthalmol Vis Sci. 2008; 49: 910-916.
31. Li B, Sheng M, Xie L, et al. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by twodimensional nano-liquid chromatography coupled with tandem mass spectrometry. Invest Ophthalmol Vis Sci. 2014; 55: 177-186.
32. Efron N. Assessing diabetic neuropathy using corneal confocal microscopy. Invest Ophthalmol Vis Sci. 2012; 53: 8075.
33. Misra SM, Craig JP, McGhee CNJ, Patel DV. Interocular comparison by in vivo confocal microscopy of the 2-dimensional architecture of the normal human corneal subbasal nerve plexus. Cornea. 2012; 31: 1376-1380.